{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:85672"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:85672","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Development of a cardiometabolic disease policy model: leveraging the role of UK primary care data","abstract":"Cardiometabolic diseases, including type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), pose a growing public health burden globally and in the UK. Effective policy responses require robust modeling tools to evaluate the long-term clinical and economic impacts, particularly for preventative interventions. This thesis presents the development of a cardiometabolic disease (CMD) policy model designed to simulate the natural history and progression of major cardiometabolic conditions. The model adopts a multi-state survival analysis model with semi-Markov structure, by utilising real-world patient-level data from the Clinical Practice Research Datalink (CPRD) Aurum, linked with Hospital Episode Statistics (HES), mortality records, and the Index of Multiple Deprivation (IMD). It estimates transition probabilities across key health states: disease-free, T2DM, first and recurrent cardiovascular events, and death. Both parametric and flexible survival models are explored to estimate transition risks and enable long-term extrapolation. The model also incorporates time-dependent covariates, allowing risks to evolve as patient characteristics change. Model performance is assessed through rigorous diagnostics and validation. A key feature of this model is its hybrid approach, which combines cohort-based transitions with microsimulation components. This structure captures both population-level trends and individual-level heterogeneity, enhancing the model’s flexibility and relevance for policy analysis. Model outputs include life-years, quality-adjusted life years (QALYs), and healthcare costs, with also the extended ability to assess outcomes across different ethnic groups and explore health inequalities. This CMD policy model offers a flexible, real-world-informed decision-support tool for policymakers, health economists, and public health planners. Its hybrid structure provides a foundation for supporting the long-term clinical and economic impacts of interventions to reduce the burden of cardiometabolic diseases in the UK population.","abstract_html":"Cardiometabolic diseases, including type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), pose a growing public health burden globally and in the UK. Effective policy responses require robust modeling tools to evaluate the long-term clinical and economic impacts, particularly for preventative interventions. This thesis presents the development of a cardiometabolic disease (CMD) policy model designed to simulate the natural history and progression of major cardiometabolic conditions. The model adopts a multi-state survival analysis model with semi-Markov structure, by utilising real-world patient-level data from the Clinical Practice Research Datalink (CPRD) Aurum, linked with Hospital Episode Statistics (HES), mortality records, and the Index of Multiple Deprivation (IMD). It estimates transition probabilities across key health states: disease-free, T2DM, first and recurrent cardiovascular events, and death. Both parametric and flexible survival models are explored to estimate transition risks and enable long-term extrapolation. The model also incorporates time-dependent covariates, allowing risks to evolve as patient characteristics change. Model performance is assessed through rigorous diagnostics and validation. A key feature of this model is its hybrid approach, which combines cohort-based transitions with microsimulation components. This structure captures both population-level trends and individual-level heterogeneity, enhancing the model’s flexibility and relevance for policy analysis. Model outputs include life-years, quality-adjusted life years (QALYs), and healthcare costs, with also the extended ability to assess outcomes across different ethnic groups and explore health inequalities. This CMD policy model offers a flexible, real-world-informed decision-support tool for policymakers, health economists, and public health planners. Its hybrid structure provides a foundation for supporting the long-term clinical and economic impacts of interventions to reduce the burden of cardiometabolic diseases in the UK population.","abstract_has_math":false,"creators":["Putri, Septiara"],"institution":"University of Glasgow","degree_name":null,"degree_level":"PhD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-19T08:37:25Z","subjects":["R Medicine (General)"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.5525/gla.thesis.85672","outbound_label":"DOI","outbound_source":"dc:identifier.doi","record_url":"https://doi.org/10.5525/gla.thesis.85672","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier.doi","download_url":"https://theses.gla.ac.uk/85672/2/2025PutriPhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A85672","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Putri, Septiara"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:date.issued","label":"Date","values":["2025"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/85672/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["R Medicine (General)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.5525/gla.thesis.85672"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/85672/2/2025PutriPhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cardiometabolic diseases, including type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), pose a growing public health burden globally and in the UK. Effective policy responses require robust modeling tools to evaluate the long-term clinical and economic impacts, particularly for preventative interventions. This thesis presents the development of a cardiometabolic disease (CMD) policy model designed to simulate the natural history and progression of major cardiometabolic conditions. The model adopts a multi-state survival analysis model with semi-Markov structure, by utilising real-world patient-level data from the Clinical Practice Research Datalink (CPRD) Aurum, linked with Hospital Episode Statistics (HES), mortality records, and the Index of Multiple Deprivation (IMD). It estimates transition probabilities across key health states: disease-free, T2DM, first and recurrent cardiovascular events, and death. Both parametric and flexible survival models are explored to estimate transition risks and enable long-term extrapolation. The model also incorporates time-dependent covariates, allowing risks to evolve as patient characteristics change. Model performance is assessed through rigorous diagnostics and validation. A key feature of this model is its hybrid approach, which combines cohort-based transitions with microsimulation components. This structure captures both population-level trends and individual-level heterogeneity, enhancing the model’s flexibility and relevance for policy analysis. Model outputs include life-years, quality-adjusted life years (QALYs), and healthcare costs, with also the extended ability to assess outcomes across different ethnic groups and explore health inequalities. This CMD policy model offers a flexible, real-world-informed decision-support tool for policymakers, health economists, and public health planners. Its hybrid structure provides a foundation for supporting the long-term clinical and economic impacts of interventions to reduce the burden of cardiometabolic diseases in the UK population."]},{"key":"dc:format","label":"Dc Format","values":["pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Development of a cardiometabolic disease policy model: leveraging the role of UK primary care data"]}]}],"canonical_facts":{"dc:creator":["Putri, Septiara"],"dc:date":["2025"],"dc:date.issued":["2025"],"dc:description.abstract":["Cardiometabolic diseases, including type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), pose a growing public health burden globally and in the UK. Effective policy responses require robust modeling tools to evaluate the long-term clinical and economic impacts, particularly for preventative interventions. This thesis presents the development of a cardiometabolic disease (CMD) policy model designed to simulate the natural history and progression of major cardiometabolic conditions. The model adopts a multi-state survival analysis model with semi-Markov structure, by utilising real-world patient-level data from the Clinical Practice Research Datalink (CPRD) Aurum, linked with Hospital Episode Statistics (HES), mortality records, and the Index of Multiple Deprivation (IMD). It estimates transition probabilities across key health states: disease-free, T2DM, first and recurrent cardiovascular events, and death. Both parametric and flexible survival models are explored to estimate transition risks and enable long-term extrapolation. The model also incorporates time-dependent covariates, allowing risks to evolve as patient characteristics change. Model performance is assessed through rigorous diagnostics and validation. A key feature of this model is its hybrid approach, which combines cohort-based transitions with microsimulation components. This structure captures both population-level trends and individual-level heterogeneity, enhancing the model’s flexibility and relevance for policy analysis. Model outputs include life-years, quality-adjusted life years (QALYs), and healthcare costs, with also the extended ability to assess outcomes across different ethnic groups and explore health inequalities. This CMD policy model offers a flexible, real-world-informed decision-support tool for policymakers, health economists, and public health planners. Its hybrid structure provides a foundation for supporting the long-term clinical and economic impacts of interventions to reduce the burden of cardiometabolic diseases in the UK population."],"dc:format":["pdf"],"dc:identifier.doi":["10.5525/gla.thesis.85672"],"dc:identifier.uri":["https://theses.gla.ac.uk/85672/2/2025PutriPhD.pdf"],"dc:language":["en"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/85672/"],"dc:subject":["R Medicine (General)"],"dcterms:accessrights":["public"],"dc:title":["Development of a cardiometabolic disease policy model: leveraging the role of UK primary care data"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["PhD"]},"updated_at":"2026-11-19T08:37:25Z"}